Clinical Trials Logo

Multiple Sclerosis clinical trials

View clinical trials related to Multiple Sclerosis.

Filter by:

NCT ID: NCT05706220 Enrolling by invitation - Multiple Sclerosis Clinical Trials

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

Start date: June 13, 2022
Phase:
Study type: Observational

This project aims to analyze ocular motility problems, visual processing speed and microperimetry, and their relationship with consolidated retinal structural biomarkers (optical coherence tomography, OCT) in patients with Multiple Sclerosis w/w reading complaints comparing with healthy subjects.

NCT ID: NCT05705986 Recruiting - Clinical trials for Relapse Remitting Multiple Sclerosis

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Start date: February 26, 2021
Phase:
Study type: Observational

Microparticles (MPs) as a mode of therapeutic delivery can selectively deliver immunomodulatory treatment to the phagocytic cells, particularly dendritic cells (DCs), inducing their tolerogenic phenotype and function and T regulatory (Treg) cell expansion. The study will characterize the in vitro response of cGAMP immunomodulator incapsulated microparticles on the capacity of DCs and Tregs to regulate the inflammatory response.

NCT ID: NCT05704361 Recruiting - Multiple Sclerosis Clinical Trials

A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 in Participants With Multiple Sclerosis.

Start date: August 11, 2021
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to evaluate the safety and tolerability of single ascending intravenous (IV) (Part 1) and subcutaneous (SC) (Part 2) doses of RO7121932 and multiple ascending SC (Part 3) doses of RO7121932 in participants with multiple sclerosis (MS).

NCT ID: NCT05701423 Active, not recruiting - Multiple Sclerosis Clinical Trials

A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) Participants

SATURATE-MS
Start date: February 8, 2023
Phase:
Study type: Observational

The primary objective of this study is to better understand the pathophysiological background of end-of-dose symptoms (EOD) and thereby determine the percentage of participants who develop EOD under natalizumab (NTZ) as an example of interval therapy in MS and to detect specific changes through multimodal analyses, including radiological, blood and digital health measurements, that may be used as potential biomarkers in the future to map EOD.

NCT ID: NCT05697523 Completed - Multiple Sclerosis Clinical Trials

Multiple Sclerosis and Respiratory and Functional Capacity

Start date: January 1, 2020
Phase:
Study type: Observational [Patient Registry]

It is known that respiratory functions, physical activities and functional capacities of Multiple Sclerosis (MS) patients decrease with the progression of the disease. However, there is not enough information about the severity of the effects of these parameters in mild Relapsing-Remitting Multiple Sclerosis (RRMS) patients. Our aim in this study is to compare the respiratory functions, physical activities and functional capacities of mild RRMS patients with healthy controls and to examine the relationship between them.

NCT ID: NCT05691192 Recruiting - Multiple Sclerosis Clinical Trials

Cognitive Reserve-building Activities in Multiple Sclerosis

CRAMS
Start date: December 1, 2022
Phase: Phase 2
Study type: Interventional

The study is a crossover randomized controlled trial investigating the effect of increasing engagement in cognitive leisure activities for individuals with multiple sclerosis.

NCT ID: NCT05688436 Recruiting - Multiple Sclerosis Clinical Trials

A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Start date: September 24, 2021
Phase:
Study type: Observational [Patient Registry]

The primary objective of the study is to estimate the prevalence of major congenital malformations (MCMs) and compare the prevalence between the diroximel fumarate (DRF) and comparator groups. The secondary objectives of the study are to estimate the incidence of spontaneous abortion (SA) and compare the incidence between the DRF and comparator groups; to estimate the incidence of preterm birth and compare the incidence between the DRF and comparator groups; to estimate the incidence of stillbirth and compare the incidence between the DRF and comparator groups and to estimate the prevalence of small for gestational age (SGA) and compare the prevalence between the DRF and comparator groups.

NCT ID: NCT05685784 Recruiting - Clinical trials for Progressive Multiple Sclerosis

Multiple Sclerosis Prediction and Monitoring of Progression Study

PREMONITION
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Multiple sclerosis (MS) is a auto-immune disease that is mostly characterized by acute clinical relapses and/or focal inflammation in the central nervous system (CNS) followed by recovery. Yet, a significant part of the patients also experience a progressive decline in function. This progressive phase usually has an insidious onset causing a delay for diagnosis and adjusted therapies. There are plenty of clinical assessments available to measure walking speed, cognition, sleep,.... . But these assessments are merely a snapshot of the patient 's symptoms. By monitoring these parameters at home, real life data can be provided to capture subclinical signs of progression. The goal of this study is to detect a digital biomarker for progressive MS at an earlier stage next to validating wearables by comparing them to golden standard measurements such a polysomnography or gait analysis in a specialized lab.

NCT ID: NCT05684016 Completed - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

NeuroQuant
Start date: December 2013
Phase: N/A
Study type: Interventional

The purpose of the research study is to investigate whether the extent and severity of lesions in the brain as measured by special MRI techniques can distinguish between Multiple Sclerosis (MS) patients with or without memory impairment and also between MS patients and age matched healthy controls.

NCT ID: NCT05682963 Completed - Multiple Sclerosis Clinical Trials

Efficacy of Square- Stepping Exercises in Individuals With Multiple Sclerosis

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

Square stepping exercises can promote correct foot placement, fast and coordinated step patterns, and sensory-motor interaction. The aim of this study is to examine the effect of square stepping exercises on mobility, balance and knee joint position sense in individuals with multiple sclerosis.